Dr. Usama Gergis, MD
Claim this profileThomas Jefferson University
Studies Lymphoma
Studies Non-Hodgkin's Lymphoma
13 reported clinical trials
29 drugs studied
Area of expertise
1Lymphoma
HLA-A negative
HLA-A positive
HLA positive
2Non-Hodgkin's Lymphoma
CD19 positive
Affiliated Hospitals
Clinical Trials Usama Gergis, MD is currently running
Stem Cell Transplant
for Blood Cancers
This phase II trial studies the how well donor stem cell transplant works in treating patients with high risk hematologic malignancies. Giving total-body irradiation and chemotherapy before a donor stem cell transplant helps stop the growth of cells in the bone marrow, including normal blood-forming cells (stem cells) and cancer cells. It may also stop the patient's immune system from rejecting the donor's stem cells. When the healthy stem cells from a donor are infused into the patient they may help the patient's bone marrow make stem cells, red blood cells, white blood cells, and platelets. The donated stem cells may also replace the patient's immune cells and help destroy any remaining cancer cells.
Recruiting3 awards Phase 2
Stem Cell Transplantation
for Leukemia
This is a prospective, multi-center, Phase II study of hematopoietic cell transplantation (HCT) using human leukocyte antigen (HLA)-mismatched unrelated donors (MMUD) for peripheral blood stem cell transplant in adults and bone marrow stem cell transplant in children. Post-transplant cyclophosphamide (PTCy), tacrolimus and mycophenolate mofetil (MMF) will be used for for graft versus host disease (GVHD) prophylaxis. This trial will study how well this treatment works in patients with hematologic malignancies.
Recruiting1 award Phase 2
More about Usama Gergis, MD
Clinical Trial Related8 years of experience running clinical trials · Led 13 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Usama Gergis, MD has experience with
- Cyclophosphamide
- Mycophenolate Mofetil
- Tacrolimus
- Total-Body Irradiation
- Chemotherapy Agents
- Fludarabine
Breakdown of trials Usama Gergis, MD has run
Lymphoma
Non-Hodgkin's Lymphoma
Hematological Malignancies
Uterine Tumors
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Usama Gergis, MD specialize in?
Usama Gergis, MD focuses on Lymphoma and Non-Hodgkin's Lymphoma. In particular, much of their work with Lymphoma has involved HLA-A negative patients, or patients who are HLA-A positive.
Is Usama Gergis, MD currently recruiting for clinical trials?
Yes, Usama Gergis, MD is currently recruiting for 5 clinical trials in Philadelphia Pennsylvania. If you're interested in participating, you should apply.
Are there any treatments that Usama Gergis, MD has studied deeply?
Yes, Usama Gergis, MD has studied treatments such as Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus.
What is the best way to schedule an appointment with Usama Gergis, MD?
Apply for one of the trials that Usama Gergis, MD is conducting.
What is the office address of Usama Gergis, MD?
The office of Usama Gergis, MD is located at: Thomas Jefferson University, Philadelphia, Pennsylvania 19107 United States. This is the address for their practice at the Thomas Jefferson University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.